Global Oncology Biomarker Market Size, Status and Forecast 2024-2031

Report ID: 933877 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Lung Cancer
        1.2.3 Breast Cancer
        1.2.4 Colorectal Cancer
        1.2.5 Prostate Cancer
        1.2.6 Stomach Cancer
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Oncology Biomarker Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostics
        1.3.3 Drug Discovery And Development
        1.3.4 Prognostics
        1.3.5 Risk Assessment
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncology Biomarker Market Perspective (2016-2027)
    2.2 Oncology Biomarker Growth Trends by Regions
        2.2.1 Oncology Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncology Biomarker Historic Market Share by Regions (2016-2021)
        2.2.3 Oncology Biomarker Forecasted Market Size by Regions (2022-2027)
    2.3 Oncology Biomarker Industry Dynamic
        2.3.1 Oncology Biomarker Market Trends
        2.3.2 Oncology Biomarker Market Drivers
        2.3.3 Oncology Biomarker Market Challenges
        2.3.4 Oncology Biomarker Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncology Biomarker Players by Revenue
        3.1.1 Global Top Oncology Biomarker Players by Revenue (2016-2021)
        3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2016-2021)
    3.2 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncology Biomarker Revenue
    3.4 Global Oncology Biomarker Market Concentration Ratio
        3.4.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2020
    3.5 Oncology Biomarker Key Players Head office and Area Served
    3.6 Key Players Oncology Biomarker Product Solution and Service
    3.7 Date of Enter into Oncology Biomarker Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Biomarker Breakdown Data by Type
    4.1 Global Oncology Biomarker Historic Market Size by Type (2016-2021)
    4.2 Global Oncology Biomarker Forecasted Market Size by Type (2022-2027)

5 Oncology Biomarker Breakdown Data by Application
    5.1 Global Oncology Biomarker Historic Market Size by Application (2016-2021)
    5.2 Global Oncology Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncology Biomarker Market Size (2016-2027)
    6.2 North America Oncology Biomarker Market Size by Type
        6.2.1 North America Oncology Biomarker Market Size by Type (2016-2021)
        6.2.2 North America Oncology Biomarker Market Size by Type (2022-2027)
        6.2.3 North America Oncology Biomarker Market Size by Type (2016-2027)
    6.3 North America Oncology Biomarker Market Size by Application
        6.3.1 North America Oncology Biomarker Market Size by Application (2016-2021)
        6.3.2 North America Oncology Biomarker Market Size by Application (2022-2027)
        6.3.3 North America Oncology Biomarker Market Size by Application (2016-2027)
    6.4 North America Oncology Biomarker Market Size by Country
        6.4.1 North America Oncology Biomarker Market Size by Country (2016-2021)
        6.4.2 North America Oncology Biomarker Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncology Biomarker Market Size (2016-2027)
    7.2 Europe Oncology Biomarker Market Size by Type
        7.2.1 Europe Oncology Biomarker Market Size by Type (2016-2021)
        7.2.2 Europe Oncology Biomarker Market Size by Type (2022-2027)
        7.2.3 Europe Oncology Biomarker Market Size by Type (2016-2027)
    7.3 Europe Oncology Biomarker Market Size by Application
        7.3.1 Europe Oncology Biomarker Market Size by Application (2016-2021)
        7.3.2 Europe Oncology Biomarker Market Size by Application (2022-2027)
        7.3.3 Europe Oncology Biomarker Market Size by Application (2016-2027)
    7.4 Europe Oncology Biomarker Market Size by Country
        7.4.1 Europe Oncology Biomarker Market Size by Country (2016-2021)
        7.4.2 Europe Oncology Biomarker Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Biomarker Market Size (2016-2027)
    8.2 Asia-Pacific Oncology Biomarker Market Size by Type
        8.2.1 Asia-Pacific Oncology Biomarker Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncology Biomarker Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncology Biomarker Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncology Biomarker Market Size by Application
        8.3.1 Asia-Pacific Oncology Biomarker Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncology Biomarker Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncology Biomarker Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncology Biomarker Market Size by Region
        8.4.1 Asia-Pacific Oncology Biomarker Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncology Biomarker Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncology Biomarker Market Size (2016-2027)
    9.2 Latin America Oncology Biomarker Market Size by Type
        9.2.1 Latin America Oncology Biomarker Market Size by Type (2016-2021)
        9.2.2 Latin America Oncology Biomarker Market Size by Type (2022-2027)
        9.2.3 Latin America Oncology Biomarker Market Size by Type (2016-2027)
    9.3 Latin America Oncology Biomarker Market Size by Application
        9.3.1 Latin America Oncology Biomarker Market Size by Application (2016-2021)
        9.3.2 Latin America Oncology Biomarker Market Size by Application (2022-2027)
        9.3.3 Latin America Oncology Biomarker Market Size by Application (2016-2027)
    9.4 Latin America Oncology Biomarker Market Size by Country
        9.4.1 Latin America Oncology Biomarker Market Size by Country (2016-2021)
        9.4.2 Latin America Oncology Biomarker Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Biomarker Market Size (2016-2027)
    10.2 Middle East & Africa Oncology Biomarker Market Size by Type
        10.2.1 Middle East & Africa Oncology Biomarker Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncology Biomarker Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncology Biomarker Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncology Biomarker Market Size by Application
        10.3.1 Middle East & Africa Oncology Biomarker Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncology Biomarker Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncology Biomarker Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncology Biomarker Market Size by Country
        10.4.1 Middle East & Africa Oncology Biomarker Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncology Biomarker Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Oncology Biomarker Introduction
        11.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Details
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2016-2021)
        11.2.5 Bristol-Myers Squibb Recent Development
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Details
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Oncology Biomarker Introduction
        11.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2016-2021)
        11.3.5 Eli Lilly and Company Recent Development
    11.4 F.Hoffmann-La Roche Ltd.
        11.4.1 F.Hoffmann-La Roche Ltd. Company Details
        11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
        11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
        11.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2016-2021)
        11.4.5 F.Hoffmann-La Roche Ltd. Recent Development
    11.5 Genomic Health
        11.5.1 Genomic Health Company Details
        11.5.2 Genomic Health Business Overview
        11.5.3 Genomic Health Oncology Biomarker Introduction
        11.5.4 Genomic Health Revenue in Oncology Biomarker Business (2016-2021)
        11.5.5 Genomic Health Recent Development
    11.6 GlaxoSmithKline plc
        11.6.1 GlaxoSmithKline plc Company Details
        11.6.2 GlaxoSmithKline plc Business Overview
        11.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
        11.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2016-2021)
        11.6.5 GlaxoSmithKline plc Recent Development
    11.7 Novartis AG
        11.7.1 Novartis AG Company Details
        11.7.2 Novartis AG Business Overview
        11.7.3 Novartis AG Oncology Biomarker Introduction
        11.7.4 Novartis AG Revenue in Oncology Biomarker Business (2016-2021)
        11.7.5 Novartis AG Recent Development
    11.8 Merck & Co.
        11.8.1 Merck & Co. Company Details
        11.8.2 Merck & Co. Business Overview
        11.8.3 Merck & Co. Oncology Biomarker Introduction
        11.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2016-2021)
        11.8.5 Merck & Co. Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Oncology Biomarker Introduction
        11.9.4 Pfizer Revenue in Oncology Biomarker Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Qiagen N.V.
        11.10.1 Qiagen N.V. Company Details
        11.10.2 Qiagen N.V. Business Overview
        11.10.3 Qiagen N.V. Oncology Biomarker Introduction
        11.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2016-2021)
        11.10.5 Qiagen N.V. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Lung Cancer
    Table 3. Key Players of Breast Cancer
    Table 4. Key Players of Colorectal Cancer
    Table 5. Key Players of Prostate Cancer
    Table 6. Key Players of Stomach Cancer
    Table 7. Key Players of Others
    Table 8. Global Oncology Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncology Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Oncology Biomarker Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Oncology Biomarker Market Share by Regions (2016-2021)
    Table 12. Global Oncology Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Oncology Biomarker Market Share by Regions (2022-2027)
    Table 14. Oncology Biomarker Market Trends
    Table 15. Oncology Biomarker Market Drivers
    Table 16. Oncology Biomarker Market Challenges
    Table 17. Oncology Biomarker Market Restraints
    Table 18. Global Oncology Biomarker Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Oncology Biomarker Market Share by Players (2016-2021)
    Table 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2020)
    Table 21. Ranking of Global Top Oncology Biomarker Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Oncology Biomarker Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Oncology Biomarker Product Solution and Service
    Table 25. Date of Enter into Oncology Biomarker Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Oncology Biomarker Revenue Market Share by Type (2016-2021)
    Table 29. Global Oncology Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Oncology Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Oncology Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Oncology Biomarker Revenue Market Share by Application (2016-2021)
    Table 33. Global Oncology Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Oncology Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Oncology Biomarker Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Oncology Biomarker Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Abbott Laboratories Company Details
    Table 66. Abbott Laboratories Business Overview
    Table 67. Abbott Laboratories Oncology Biomarker Product
    Table 68. Abbott Laboratories Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 69. Abbott Laboratories Recent Development
    Table 70. Bristol-Myers Squibb Company Details
    Table 71. Bristol-Myers Squibb Business Overview
    Table 72. Bristol-Myers Squibb Oncology Biomarker Product
    Table 73. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 74. Bristol-Myers Squibb Recent Development
    Table 75. Eli Lilly and Company Company Details
    Table 76. Eli Lilly and Company Business Overview
    Table 77. Eli Lilly and Company Oncology Biomarker Product
    Table 78. Eli Lilly and Company Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 79. Eli Lilly and Company Recent Development
    Table 80. F.Hoffmann-La Roche Ltd. Company Details
    Table 81. F.Hoffmann-La Roche Ltd. Business Overview
    Table 82. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product
    Table 83. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 84. F.Hoffmann-La Roche Ltd. Recent Development
    Table 85. Genomic Health Company Details
    Table 86. Genomic Health Business Overview
    Table 87. Genomic Health Oncology Biomarker Product
    Table 88. Genomic Health Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 89. Genomic Health Recent Development
    Table 90. GlaxoSmithKline plc Company Details
    Table 91. GlaxoSmithKline plc Business Overview
    Table 92. GlaxoSmithKline plc Oncology Biomarker Product
    Table 93. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 94. GlaxoSmithKline plc Recent Development
    Table 95. Novartis AG Company Details
    Table 96. Novartis AG Business Overview
    Table 97. Novartis AG Oncology Biomarker Product
    Table 98. Novartis AG Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 99. Novartis AG Recent Development
    Table 100. Merck & Co. Company Details
    Table 101. Merck & Co. Business Overview
    Table 102. Merck & Co. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 103. Merck & Co. Recent Development
    Table 104. Pfizer Company Details
    Table 105. Pfizer Business Overview
    Table 106. Pfizer Oncology Biomarker Product
    Table 107. Pfizer Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 108. Pfizer Recent Development
    Table 109. Qiagen N.V. Company Details
    Table 110. Qiagen N.V. Business Overview
    Table 111. Qiagen N.V. Oncology Biomarker Product
    Table 112. Qiagen N.V. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
    Table 113. Qiagen N.V. Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Biomarker Market Share by Type: 2020 VS 2027
    Figure 2. Lung Cancer Features
    Figure 3. Breast Cancer Features
    Figure 4. Colorectal Cancer Features
    Figure 5. Prostate Cancer Features
    Figure 6. Stomach Cancer Features
    Figure 7. Others Features
    Figure 8. Global Oncology Biomarker Market Share by Application: 2020 VS 2027
    Figure 9. Diagnostics Case Studies
    Figure 10. Drug Discovery And Development Case Studies
    Figure 11. Prognostics Case Studies
    Figure 12. Risk Assessment Case Studies
    Figure 13. Others Case Studies
    Figure 14. Oncology Biomarker Report Years Considered
    Figure 15. Global Oncology Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Oncology Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Oncology Biomarker Market Share by Regions: 2020 VS 2027
    Figure 18. Global Oncology Biomarker Market Share by Regions (2022-2027)
    Figure 19. Global Oncology Biomarker Market Share by Players in 2020
    Figure 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2020
    Figure 22. Global Oncology Biomarker Revenue Market Share by Type (2016-2021)
    Figure 23. Global Oncology Biomarker Revenue Market Share by Type (2022-2027)
    Figure 24. North America Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Oncology Biomarker Market Share by Type (2016-2027)
    Figure 26. North America Oncology Biomarker Market Share by Application (2016-2027)
    Figure 27. North America Oncology Biomarker Market Share by Country (2016-2027)
    Figure 28. United States Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Oncology Biomarker Market Share by Type (2016-2027)
    Figure 32. Europe Oncology Biomarker Market Share by Application (2016-2027)
    Figure 33. Europe Oncology Biomarker Market Share by Country (2016-2027)
    Figure 34. Germany Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Oncology Biomarker Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Oncology Biomarker Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Oncology Biomarker Market Share by Region (2016-2027)
    Figure 44. China Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Oncology Biomarker Market Share by Type (2016-2027)
    Figure 52. Latin America Oncology Biomarker Market Share by Application (2016-2027)
    Figure 53. Latin America Oncology Biomarker Market Share by Country (2016-2027)
    Figure 54. Mexico Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Oncology Biomarker Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Oncology Biomarker Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Oncology Biomarker Market Share by Country (2016-2027)
    Figure 60. Turkey Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 65. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 66. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 67. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 68. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 69. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 70. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 71. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 72. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Pfizer
Qiagen N.V.
Frequently Asked Questions
Oncology Biomarker report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Biomarker report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Biomarker report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Counter Drone

Counter drone technology refers to the system used to detect, obstruct and even destroy the unaut ... Read More

Aviation Refueling

Aviation refueling refers to the process of transferring aviation fuel from the fuel station to t ... Read More